Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae

Kelsey Shelton-Dodge, Emily A. Vetter, Peggy C. Kohner, Lisa M. Nyre, Robin Patel

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A retrospective chart review was performed on 92 patients from whom 118 isolates of Aerococcus sanguinicola (n = 52) or Aerococcus urinae (n = 66) were obtained from urine cultures between October 2007 and June 2008 to assess clinical presentation and antimicrobial susceptibilities. The mean patient age was 82 (range 24-101) years. The majority was female (76% and 87% for A. sanguinicola and A. urinae, respectively) and institutionalized (61% and 60%, respectively). The majority of male patients had underlying prostatic disease (55% and 63%, respectively). Thirty-one of 46 patients with A. sanguinicola and 45 of 57 patients with A. urinae isolated from the urine had a clinical diagnosis of urinary tract infection. One subject had A. sanguinicola isolated from blood cultures. A. sanguinicola and A. urinae had low ceftriaxone, penicillin, and vancomycin MICs. MICs to erythromycin and levofloxacin were ≥0.5 and >4 μg/mL in 41% and 78% of A. sanguinicola and 17% and 23% of A. urinae isolates, respectively. In conclusion, A. sanguinicola and A. urinae are not infrequent causes of urinary tract infection and most A. sanguinicola isolates have elevated MICs to levofloxacin.

Original languageEnglish (US)
Pages (from-to)448-451
Number of pages4
JournalDiagnostic Microbiology and Infectious Disease
Volume70
Issue number4
DOIs
StatePublished - Aug 2011

Fingerprint

Aerococcus
Levofloxacin
Urinary Tract Infections
Urine
Prostatic Diseases
Ceftriaxone
Erythromycin
Vancomycin
Penicillins

Keywords

  • Aerococcus sanguinicola
  • Aerococcus species
  • Aerococcus urinae
  • Antimicrobial susceptibilities

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae. / Shelton-Dodge, Kelsey; Vetter, Emily A.; Kohner, Peggy C.; Nyre, Lisa M.; Patel, Robin.

In: Diagnostic Microbiology and Infectious Disease, Vol. 70, No. 4, 08.2011, p. 448-451.

Research output: Contribution to journalArticle

Shelton-Dodge, Kelsey ; Vetter, Emily A. ; Kohner, Peggy C. ; Nyre, Lisa M. ; Patel, Robin. / Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae. In: Diagnostic Microbiology and Infectious Disease. 2011 ; Vol. 70, No. 4. pp. 448-451.
@article{5a691aa5d09040868358e6ede042334c,
title = "Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae",
abstract = "A retrospective chart review was performed on 92 patients from whom 118 isolates of Aerococcus sanguinicola (n = 52) or Aerococcus urinae (n = 66) were obtained from urine cultures between October 2007 and June 2008 to assess clinical presentation and antimicrobial susceptibilities. The mean patient age was 82 (range 24-101) years. The majority was female (76{\%} and 87{\%} for A. sanguinicola and A. urinae, respectively) and institutionalized (61{\%} and 60{\%}, respectively). The majority of male patients had underlying prostatic disease (55{\%} and 63{\%}, respectively). Thirty-one of 46 patients with A. sanguinicola and 45 of 57 patients with A. urinae isolated from the urine had a clinical diagnosis of urinary tract infection. One subject had A. sanguinicola isolated from blood cultures. A. sanguinicola and A. urinae had low ceftriaxone, penicillin, and vancomycin MICs. MICs to erythromycin and levofloxacin were ≥0.5 and >4 μg/mL in 41{\%} and 78{\%} of A. sanguinicola and 17{\%} and 23{\%} of A. urinae isolates, respectively. In conclusion, A. sanguinicola and A. urinae are not infrequent causes of urinary tract infection and most A. sanguinicola isolates have elevated MICs to levofloxacin.",
keywords = "Aerococcus sanguinicola, Aerococcus species, Aerococcus urinae, Antimicrobial susceptibilities",
author = "Kelsey Shelton-Dodge and Vetter, {Emily A.} and Kohner, {Peggy C.} and Nyre, {Lisa M.} and Robin Patel",
year = "2011",
month = "8",
doi = "10.1016/j.diagmicrobio.2010.09.001",
language = "English (US)",
volume = "70",
pages = "448--451",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Clinical significance and antimicrobial susceptibilities of Aerococcus sanguinicola and Aerococcus urinae

AU - Shelton-Dodge, Kelsey

AU - Vetter, Emily A.

AU - Kohner, Peggy C.

AU - Nyre, Lisa M.

AU - Patel, Robin

PY - 2011/8

Y1 - 2011/8

N2 - A retrospective chart review was performed on 92 patients from whom 118 isolates of Aerococcus sanguinicola (n = 52) or Aerococcus urinae (n = 66) were obtained from urine cultures between October 2007 and June 2008 to assess clinical presentation and antimicrobial susceptibilities. The mean patient age was 82 (range 24-101) years. The majority was female (76% and 87% for A. sanguinicola and A. urinae, respectively) and institutionalized (61% and 60%, respectively). The majority of male patients had underlying prostatic disease (55% and 63%, respectively). Thirty-one of 46 patients with A. sanguinicola and 45 of 57 patients with A. urinae isolated from the urine had a clinical diagnosis of urinary tract infection. One subject had A. sanguinicola isolated from blood cultures. A. sanguinicola and A. urinae had low ceftriaxone, penicillin, and vancomycin MICs. MICs to erythromycin and levofloxacin were ≥0.5 and >4 μg/mL in 41% and 78% of A. sanguinicola and 17% and 23% of A. urinae isolates, respectively. In conclusion, A. sanguinicola and A. urinae are not infrequent causes of urinary tract infection and most A. sanguinicola isolates have elevated MICs to levofloxacin.

AB - A retrospective chart review was performed on 92 patients from whom 118 isolates of Aerococcus sanguinicola (n = 52) or Aerococcus urinae (n = 66) were obtained from urine cultures between October 2007 and June 2008 to assess clinical presentation and antimicrobial susceptibilities. The mean patient age was 82 (range 24-101) years. The majority was female (76% and 87% for A. sanguinicola and A. urinae, respectively) and institutionalized (61% and 60%, respectively). The majority of male patients had underlying prostatic disease (55% and 63%, respectively). Thirty-one of 46 patients with A. sanguinicola and 45 of 57 patients with A. urinae isolated from the urine had a clinical diagnosis of urinary tract infection. One subject had A. sanguinicola isolated from blood cultures. A. sanguinicola and A. urinae had low ceftriaxone, penicillin, and vancomycin MICs. MICs to erythromycin and levofloxacin were ≥0.5 and >4 μg/mL in 41% and 78% of A. sanguinicola and 17% and 23% of A. urinae isolates, respectively. In conclusion, A. sanguinicola and A. urinae are not infrequent causes of urinary tract infection and most A. sanguinicola isolates have elevated MICs to levofloxacin.

KW - Aerococcus sanguinicola

KW - Aerococcus species

KW - Aerococcus urinae

KW - Antimicrobial susceptibilities

UR - http://www.scopus.com/inward/record.url?scp=79960371511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960371511&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2010.09.001

DO - 10.1016/j.diagmicrobio.2010.09.001

M3 - Article

VL - 70

SP - 448

EP - 451

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 4

ER -